1. Market Research
  2. > Software Market Trends
  3. > Pharmacovigilance and Drug Safety Software Market by Functionality, Delivery Mode, End-user - Global Forecast to 2019

The global pharmacovigilance and drug safety software market is expected to grow at a CAGR of 6.5% from 2014 to 2019. North America region held the largest share of the pharmacovigilance and drug safety software market in 2014. However, Asian and Latin American countries symbolize high growth markets. This is owing to a rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations.

The growth of the global pharmacovigilance and drug safety software market is mainly driven by increasing incidence rates of adverse drug reactions (ADRs), growing adoption of pharmacovigilance software by outsourcing companies (such as CROs and BPOs), and huge pressure on pharma companies to develop novel and safe drugs.

However, the dearth of standard regulations and lack of pharmacovigilance professionals are some of the key factors restraining the growth of this market.

In this report, the global pharmacovigilance and drug safety software market has been classified into four segments on the basis of functionality, namely, adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software. The global pharmacovigilance and drug safety software market is segmented into two segments on the basis of delivery mode, namely, on-premise delivery mode and on-demand/cloud based (SaaS) delivery mode. The global pharmacovigilance and drug safety software market is also segmented on the basis of end users including pharma and biotech companies, contract research organizations (CROs), business process outsourcing (BPO) firms, and other pharmacovigilance service providers.

The global pharmacovigilance and drug safety software market comprises large number of small and mid-size software developers and service providers. As of 2014, the global pharmacovigilance and drug safety software market was dominated by Oracle Corporation (U.S.).

New service launches; agreements, and partnerships; software developments; and geographical expansions are some of the major strategies adopted by most of the market players to achieve growth in the pharmacovigilance and drug safety software market.

Reasons to Buy the Report:
From an insight perspective, this research report focuses on various levels of analysis —industry analysis (value chain analysis and Porter’s five force model), market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the pharmacovigilance and drug safety software market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them to garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned four strategies (market penetration, market development, market diversification, and competitive assessment) for strengthening their market shares.


The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on pharmacovigilance and drug safety software offered by the top 10 players in the pharmacovigilance and drug safety software market. The report analyzes the pharmacovigilance and drug safety software market on the basis of functionality, delivery mode, end user, and region.

- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various pharmacovigilance and drug safety software across geographies.

- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmacovigilance and drug safety software market.

- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the pharmacovigilance and drug safety software market.

Table Of Contents

Pharmacovigilance and Drug Safety Software Market by Functionality, Delivery Mode, End-user - Global Forecast to 2019
TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Key data from primary sources 21
2.1.2.2 Key industry insights 22
2.1.2.3 Breakdown of primaries 22
2.2 MARKET SIZE ESTIMATION 23
2.2.1 BOTTOM-UP APPROACH 23
2.2.2 TOP-DOWN APPROACH 24
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.4 RESEARCH ASSUMPTIONS 26
2.4.1 ASSUMPTIONS 26
3 EXECUTIVE SUMMARY 27
3.1 INTRODUCTION 27
3.2 CURRENT SCENARIO 28
3.3 FUTURE OUTLOOK 29
3.4 CONCLUSION 30
4 PREMIUM INSIGHTS 31
4.1 ATTRACTIVE MARKET OPPORTUNITIES IN THE GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET 31
4.2 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY FUNCTIONALITY 32
4.3 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY END USER 33
4.4 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY REGION 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.2 MARKET SEGMENTATION 36
5.2.1 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,
BY FUNCTIONALITY 36
5.2.2 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,
BY DELIVERY MODE 37
5.2.3 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,
BY END USER 37
5.3 MARKET DYNAMICS 38
5.3.1 KEY MARKET DRIVERS 38
5.3.1.1 Intensification of drug safety regulations by government authorities 38
5.3.1.2 Heavy clinical RandD expenditure by the pharmaceutical industry 39
5.3.1.3 Benefits offered by PV solutions—reduced cost and time involved in clinical trial processes 39
5.3.1.4 Government grants to support clinical trials 39
5.3.1.5 Large investments in healthcare IT by governments from mature as well as developing nations 40
5.3.2 KEY MARKET RESTRAINTS 41
5.3.2.1 Dearth of healthcare IT professionals 41
5.3.2.2 Cultural differences and language barriers 42
5.3.3 KEY MARKET OPPORTUNITIES 42
5.3.3.1 Cloud technology provides opportunities for industry players 42
5.3.3.2 Emerging markets to offer high growth opportunities 42
5.3.4 KEY MARKET CHALLENGES 43
5.3.4.1 Lack of standardization and harmonization of drug safety regulations 43
5.3.4.2 Low adoption of pharmacovigilance solutions in the least developed countries 43
6 INDUSTRY INSIGHTS 45
6.1 INTRODUCTION 45
6.2 PORTER'S FIVE FORCES ANALYSIS 45
6.2.1 THREAT FROM NEW ENTRANTS 46
6.2.2 THREAT FROM SUBSTITUTES 47
6.2.3 BARGAINING POWER OF SUPPLIERS 47
6.2.4 BARGAINING POWER OF BUYERS 48
6.2.5 INTENSITY OF COMPETITIVE RIVALRY 48
6.3 INDUSTRY TRENDS 49
6.3.1 STRONG FOCUS ON NEW PRODUCT LAUNCHES 49
6.3.2 GROWING MARKET PREFERENCE FOR CLOUD-BASED PLATFORMS 49

7 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,
BY FUNCTIONALITY 50
7.1 INTRODUCTION 51
7.2 ADVERSE EVENT REPORTING SOFTWARE 52
7.3 DRUG SAFETY AUDIT SOFTWARE 53
7.4 FULLY INTEGRATED SOFTWARE 53
7.5 ISSUE TRACKING SOFTWARE 54
8 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,
BY DELIVERY MODE 55
8.1 INTRODUCTION 56
8.2 ON-PREMISE DELIVERY MODE 57
8.3 ON-DEMAND/CLOUD-BASED (SAAS) DELIVERY MODE 57
9 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY END USER 59
9.1 INTRODUCTION 60
9.2 CONTRACT RESEARCH ORGANIZATIONS (CROS) 61
9.3 PHARMA AND BIOTECH COMPANIES 62
9.4 BUSINESS PROCESS OUTSOURCING (BPO) FIRMS 63
9.5 OTHER PHARMACOVIGILANCE SERVICE PROVIDERS 64
10 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY REGION 66
10.1 INTRODUCTION 67
10.2 NORTH AMERICA 68
10.2.1 U.S. 71
10.2.2 CANADA 73
10.3 EUROPE 75
10.3.1 GERMANY 78
10.3.2 U.K. 80
10.3.3 FRANCE 81
10.3.4 REST OF EUROPE 83
10.4 ASIA-PACIFIC 84
10.4.1 JAPAN 87
10.4.2 CHINA 89
10.4.3 INDIA 90
10.4.4 REST OF ASIA-PACIFIC 92
10.5 ROW (REST OF THE WORLD) 93
10.5.1 LATIN AMERICA 95
10.5.2 MIDDLE EAST 97
10.5.3 AFRICA 98
11 COMPETITIVE LANDSCAPE 101
11.1 OVERVIEW 101
11.2 MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014 102
11.3 COMPETITIVE SITUATION AND TRENDS 103
11.4 RECENT DEVELOPMENTS 104
11.4.1 NEW PRODUCT LAUNCHES 104
11.4.2 ACQUISITIONS, PARTNERSHIPS, AND AGREEMENTS 105
11.4.3 NEW SERVICE LAUNCHES AND SERVICE EXPANSIONS 106
11.4.4 GEOGRAPHICAL EXPANSIONS 106
11.4.5 OTHER DEVELOPMENTS 107
12 COMPANY PROFILES 108
12.1 INTRODUCTION 108
12.2 ORACLE CORPORATION 108
12.2.1 BUSINESS OVERVIEW 108
12.2.2 PRODUCT PORTFOLIO 109
12.2.3 KEY STRATEGY 109
12.2.4 RECENT DEVELOPMENTS 109
12.2.5 SWOT ANALYSIS 110
12.3 ARISGLOBAL LLC 111
12.3.1 BUSINESS OVERVIEW 111
12.3.2 PRODUCTS and SERVICES 111
12.3.3 KEY STRATEGY 112
12.3.4 RECENT DEVELOPMENTS 112
12.3.5 SWOT ANALYSIS 114
12.4 EXTEDO GMBH 115
12.4.1 BUSINESS OVERVIEW 115
12.4.2 PRODUCTS and SERVICES 115
12.4.3 KEY STRATEGY 115
12.4.4 SWOT ANALYSIS 116
12.5 AB-CUBE 117
12.5.1 BUSINESS OVERVIEW 117
12.5.2 PRODUCT and SERVICES 117
12.5.3 KEY STRATEGY 117
12.6 ENNOV SOLUTIONS, INC. 118
12.6.1 BUSINESS OVERVIEW 118
12.6.2 PRODUCTS and SERVICES 118
12.6.3 KEY STRATEGY 118
12.6.4 RECENT DEVELOPMENTS 119

12.7 ONLINE BUSINESS APPLICATIONS, INC. 120
12.7.1 BUSINESS OVERVIEW 120
12.7.2 PRODUCTS and SERVICES 120
12.7.3 KEY STRATEGY 120
12.7.4 RECENT DEVELOPMENTS 121
12.8 SARJEN SYSTEMS PVT. LTD. 122
12.8.1 BUSINESS OVERVIEW 122
12.8.2 PRODUCTS and SERVICES 122
12.8.3 KEY STRATEGY 123
12.9 SPARTA SYSTEMS, INC. 124
12.9.1 BUSINESS OVERVIEW 124
12.9.2 PRODUCTS and SERVICES 124
12.9.3 KEY STRATEGY 124
12.9.4 RECENT DEVELOPMENTS 125
12.10 UMBRA GLOBAL, LLC 127
12.10.1 BUSINESS OVERVIEW 127
12.10.2 PRODUCTS and SERVICES 127
12.10.3 KEY STRATEGY 127
12.10.4 RECENT DEVELOPMENTS 128
12.11 UNITED BIOSOURCE CORPORATION (AN EXPRESS SCRIPTS COMPANY) 129
12.11.1 BUSINESS OVERVIEW 129
12.11.2 SERVICES PORTFOLIO 129
12.11.3 KEY STRATEGY 129
12.11.4 RECENT DEVELOPMENTS 129
13 APPENDIX 130
13.1 INSIGHTS OF INDUSTRY EXPERTS 130
13.2 DISCUSSION GUIDE 131
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 134
13.4 AVAILABLE CUSTOMIZATIONS 134
13.5 RELATED REPORTS 135


LIST OF TABLES

TABLE 1 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,
BY FUNCTIONALITY, 2012-2019 ($MILLION) 52
TABLE 2 ADVERSE EVENT REPORTING SOFTWARE MARKET, BY REGION,
2012-2019 ($MILLION) 52
TABLE 3 DRUG SAFETY AUDIT SOFTWARE MARKET, BY REGION, 2012-2019 ($MILLION) 53
TABLE 4 FULLY INTEGRATED SOFTWARE MARKET, BY REGION 2012-2019 ($MILLION) 54
TABLE 5 ISSUE TRACKING SOFTWARE MARKET, BY REGION 2012-2019 ($MILLION) 54
TABLE 6 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,
BY DELIVERY MODE 2012-2019 ($MILLION) 56
TABLE 7 ON-PREMISE PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,
BY REGION 2012-2019 ($MILLION) 57
TABLE 8 ON-DEMAND/CLOUD-BASED PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY REGION 2012-2019 ($MILLION) 58
TABLE 9 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY END USER, 2012-2019 ($MILLION) 61
TABLE 10 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2012-2019 ($MILLION) 62
TABLE 11 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE FOR PHARMA AND BIOTECH COMPANIES, BY REGION, 2012-2019 ($MILLION) 63
TABLE 12 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE FOR BUSINESS PROCESS OUTSOURCING FIRMS, BY REGION, 2012-2019 ($MILLION) 64
TABLE 13 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE FOR OTHER SERVICE PROVIDERS, BY REGION, 2012-2019 ($MILLION) 65
TABLE 14 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 68
TABLE 15 NORTH AMERICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 70
TABLE 16 NORTH AMERICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2012-2019 ($MILLION) 70
TABLE 17 NORTH AMERICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2012-2019 ($MILLION) 71
TABLE 18 NORTH AMERICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 71
TABLE 19 U.S.: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY FUNCTIONALITY, 2012-2019 ($MILLION) 72
TABLE 20 U.S.: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY DELIVERY MODE, 2012-2019 ($MILLION) 72
TABLE 21 U.S.: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY END USER, 2012-2019 ($MILLION) 73
TABLE 22 CANADA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY FUNCTIONALITY, 2012-2019 ($MILLION) 74
TABLE 23 CANADA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY DELIVERY MODE, 2012-2019 ($MILLION) 74
TABLE 24 CANADA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY END USER, 2012-2019 ($MILLION) 74
TABLE 25 EUROPE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 77
TABLE 26 EUROPE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY FUNCTIONALITY, 2012-2019 ($MILLION) 77
TABLE 27 EUROPEAN PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2012-2019 ($MILLION) 77
TABLE 28 EUROPE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY END USER, 2012-2019 ($MILLION) 78
TABLE 29 GERMANY: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2012-2019 ($MILLION) 79
TABLE 30 GERMANY: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2012-2019 ($MILLION) 79
TABLE 31 GERMANY: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 79
TABLE 32 U.K.: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY FUNCTIONALITY, 2012-2019 ($MILLION) 80
TABLE 33 U.K.: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY DELIVERY MODE, 2012-2019 ($MILLION) 81
TABLE 34 U.K.: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY END USER, 2012-2019 ($MILLION) 81
TABLE 35 FRANCE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY FUNCTIONALITY, 2012-2019 ($MILLION) 82
TABLE 36 FRANCE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY DELIVERY MODE, 2012-2019 ($MILLION) 82
TABLE 37 FRANCE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY END USER, 2012-2019 ($MILLION) 83
TABLE 38 ROE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY FUNCTIONALITY, 2012-2019 ($MILLION) 83
TABLE 39 ROE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY DELIVERY MODE, 2012-2019 ($MILLION) 84
TABLE 40 ROE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 84
TABLE 41 ASIA-PACIFIC: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 86
TABLE 42 ASIA-PACIFIC: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2012-2019 ($MILLION) 86
TABLE 43 ASIA-PACIFIC: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2012-2019 ($MILLION) 87
TABLE 44 ASIA-PACIFIC: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 87
TABLE 45 JAPAN: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY FUNCTIONALITY, 2012-2019 ($MILLION) 88
TABLE 46 JAPAN: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY DELIVERY MODE, 2012-2019 ($MILLION) 88
TABLE 47 JAPAN: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY END USER, 2012-2019 ($MILLION) 88
TABLE 48 CHINA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY FUNCTIONALITY, 2012-2019 ($MILLION) 89
TABLE 49 CHINA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY DELIVERY MODE, 2012-2019 ($MILLION) 90
TABLE 50 CHINA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY END USER, 2012-2019 ($MILLION) 90
TABLE 51 INDIA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY FUNCTIONALITY, 2012-2019 ($MILLION) 91
TABLE 52 INDIA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY DELIVERY MODE, 2012-2019 ($MILLION) 91
TABLE 53 INDIA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY END USER, 2012-2019 ($MILLION) 92
TABLE 54 ROAPAC: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY FUNCTIONALITY, 2012-2019 ($MILLION) 92
TABLE 55 ROAPAC: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY DELIVERY MODE, 2012-2019 ($MILLION) 93
TABLE 56 ROAPAC: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY END USER, 2012-2019 ($MILLION) 93
TABLE 57 ROW: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY REGION, 2012-2019 ($MILLION) 94
TABLE 58 ROW: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY FUNCTIONALITY, 2012-2019 ($MILLION) 94
TABLE 59 ROW: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY DELIVERY MODE, 2012-2019 ($MILLION) 94
TABLE 60 ROW: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY END USER, 2012-2019 ($MILLION) 95
TABLE 61 LATIN AMERICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2012-2019 ($MILLION) 96
TABLE 62 LATIN AMERICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2012-2019 ($MILLION) 96
TABLE 63 LATIN AMERICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 96
TABLE 64 MIDDLE EAST: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2012-2019 ($MILLION) 97
TABLE 65 MIDDLE EAST: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2012-2019 ($MILLION) 98
TABLE 66 MIDDLE EAST: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 98
TABLE 67 AFRICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY FUNCTIONALITY, 2012-2019 ($MILLION) 99
TABLE 68 AFRICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY DELIVERY MODE, 2012-2019 ($MILLION) 99
TABLE 69 AFRICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,
BY END USER, 2012-2019 ($MILLION) 100
TABLE 70 TOP 5 NEW PRODUCT LAUNCHES, 2012-2014 104
TABLE 71 TOP 5 ACQUISITIONS, PARTNERSHIPS, AND AGREEMENTS, 2012-2014 105
TABLE 72 TOP 5 NEW SERVICE LAUNCHES AND SERVICE EXPANSIONS, 2012-2014 106
TABLE 73 GEOGRAPHICAL EXPANSIONS, 2012-2014 107
TABLE 74 TOP 5 OTHER DEVELOPMENTS, 2012-2014 107


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 19
FIGURE 2 BOTTOM-UP APPROACH 23
FIGURE 3 TOP-DOWN APPROACH 24
FIGURE 4 DATA TRIANGULATION 25
FIGURE 5 ASSUMPTIONS OF THE RESEARCH STUDY 26
FIGURE 6 ADVERSE EVENT REPORTING SOFTWARE SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET OVER THE NEXT FIVE YEARS 27
FIGURE 7 NORTH AMERICA COMMANDED THE LARGEST SHARE OF THE PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, 2014 28
FIGURE 8 THE ON-PREMISE DELIVERY MODE SEGMENT WILL DRIVE THE GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET DURING
2014-2019 29
FIGURE 9 THE CROS SEGMENT ACCOUNTED FOR A MAJOR SHARE OF THE GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET IN 2014 30
FIGURE 10 INTENSIFICATION OF DRUG SAFETY REGULATIONS BY GOVERNMENT BODIES IS PROPELLING THE MARKET GROWTH 31
FIGURE 11 ADVERSE EVENT REPORTING SOFTWARE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE GLOBAL MARKET IN 2014 32
FIGURE 12 BUSINESS PROCESS OUTSOURCING (BPO) FIRMS TO GROW AT A HIGHER RATE DURING THE FORECAST PERIOD 33
FIGURE 13 NORTH AMERICA DOMINATES THE GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET 34
FIGURE 14 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,
BY FUNCTIONALITY 36
FIGURE 15 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY DELIVERY MODE 37
FIGURE 16 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY END USER 37
FIGURE 17 INCREASING DRUG SAFETY REGULATIONS TO PROPEL THE DEMAND FOR PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE 38
FIGURE 18 INTENSIFICATION OF DRUG SAFETY REGULATIONS BY GOVERNMENT AUTHORITIES DRIVING MARKET GROWTH 41
FIGURE 19 DEARTH OF SKILLS AND EXPERTISE FOR CONDUCTING CLINICAL TRIALS RESTRAINING MARKET GROWTH 42
FIGURE 20 INCREASING DEMAND FOR CLOUD TECHNOLOGY, A NEW GROWING OPPORTUNITY FOR MARKET PLAYERS 43
FIGURE 21 LACK OF STANDARDIZATION AND HARMONIZATION OF DRUG SAFETY REGULATIONS IS A KEY CHALLENGE TO THE MARKET 44
FIGURE 22 PRESENCE OF LARGE NUMBER OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IS DRIVING THE GROWTH OF THE MARKET 46
FIGURE 23 ADVERSE EVENT REPORTING SOFTWARE HOLDS LARGEST SHARE OF THE MARKET 51
FIGURE 24 ON-PREMISE DELIVERY MODE SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST SHARE IN THE MARKET DURING 2014-2019 56
FIGURE 25 CONTRACT RESEARCH ORGANIZATIONS (CROS) COMMANDED THE LARGEST MARKET SHARE IN THE PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET 60
FIGURE 26 NORTH AMERICA COMMANDS LION'S SHARE OF THE PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET IN 2014 67
FIGURE 27 NORTH AMERICA MARKET SNAPSHOT: DEMAND WILL BE DRIVEN BY PRESENCE OF LARGE NUMBER OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 69
FIGURE 28 EUROPE MARKET SNAPSHOT: LARGE NUMBER OF ONGOING CLINICAL TRIALS IS KEY FACTOR TO DRIVE THE MARKET GROWTH 76
FIGURE 29 ASIA-PACIFIC MARKET SNAPSHOT: INCREASING PREFERENCE OF PHARMA COMPANIES TOWARDS APAC-BASED CROS FOR CLINICAL TRIALS WILL CONTINUE TO DRIVE THE MARKET GROWTH 85
FIGURE 30 LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES AS THEIR KEY GROWTH STRATEGY FROM 2012 TO 2014 101
FIGURE 31 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SHARE,
BY KEY PLAYER, 2014 102
FIGURE 32 NEW PRODUCT LAUNCH WAS THE KEY STRATEGY 103
FIGURE 33 ORACLE CORPORATION: COMPANY SNAPSHOT 108

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
The Analytics software systems: worldwide forecast 2016–2020

The Analytics software systems: worldwide forecast 2016–2020

  • $ 7999
  • Industry report
  • October 2016
  • by Analysys Mason

This report provides forecasts for communications service provider (CSP) spending on telecoms-specific analytics software systems. It provides details of how spending will vary by delivery type, service ...

The Analytics software systems: worldwide market shares 2015

The Analytics software systems: worldwide market shares 2015

  • $ 7999
  • Industry report
  • September 2016
  • by Analysys Mason

"The telecoms industry is increasing its spending on analytics software systems, but not to the extent that we predicted last year." This report assesses which vendors are leading in the analytics software ...

Encryption Software Market by Application, Service, Deployment Type, User Type, Industry Vertical, Region - Global Forecast to 2021

Encryption Software Market by Application, Service, Deployment Type, User Type, Industry Vertical, Region - Global Forecast to 2021

  • $ 7150
  • Industry report
  • October 2016
  • by MarketsandMarkets

“Increasing need to safeguard data against cyber-attacks will drive the encryption software market” The encryption software market size is estimated to grow from USD 3.05 billion in 2016 to USD 8.94 ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.